- Home
- EBON vs GDTC Comparison
EBON vs GDTC Comparison
Compare EBON & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- GDTC
- Stock Information
- Founded
- EBON 2010
- GDTC 2018
- Country
- EBON China
- GDTC Singapore
- Employees
- EBON N/A
- GDTC N/A
- Industry
- EBON Semiconductors
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- GDTC Health Care
- Exchange
- EBON Nasdaq
- GDTC Nasdaq
- Market Cap
- EBON 25.3M
- GDTC 21.5M
- IPO Year
- EBON 2020
- GDTC 2023
- Fundamental
- Price
- EBON $4.40
- GDTC $1.86
- Analyst Decision
- EBON
- GDTC Buy
- Analyst Count
- EBON 0
- GDTC 1
- Target Price
- EBON N/A
- GDTC $5.00
- AVG Volume (30 Days)
- EBON 36.7K
- GDTC 18.1K
- Earning Date
- EBON 08-22-2025
- GDTC 01-01-0001
- Dividend Yield
- EBON N/A
- GDTC N/A
- EPS Growth
- EBON N/A
- GDTC N/A
- EPS
- EBON N/A
- GDTC N/A
- Revenue
- EBON $5,868,771.00
- GDTC $368,838.00
- Revenue This Year
- EBON N/A
- GDTC $5.37
- Revenue Next Year
- EBON N/A
- GDTC N/A
- P/E Ratio
- EBON N/A
- GDTC N/A
- Revenue Growth
- EBON 20.88
- GDTC N/A
- 52 Week Low
- EBON $3.00
- GDTC $1.20
- 52 Week High
- EBON $10.94
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- EBON 51.94
- GDTC 35.89
- Support Level
- EBON $4.25
- GDTC $1.85
- Resistance Level
- EBON $5.10
- GDTC $1.95
- Average True Range (ATR)
- EBON 0.39
- GDTC 0.10
- MACD
- EBON -0.04
- GDTC -0.02
- Stochastic Oscillator
- EBON 49.36
- GDTC 23.53
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.